BRENNTAG PACIFIC, INC

Form 483 issued May 6, 2021 · Santa Fe Springs, California

Inspection
Apr 29 – May 6, 2021
Observations
3
Pages
3
FEI number
3002820652

In short: On May 6, 2021, FDA issued a Form 483 with 3 observations to BRENNTAG PACIFIC, INC in Santa Fe Springs, California (FEI 3002820652) after an inspection that ran Apr 29 – May 6, 2021. The investigator was Dogbeda F. Mackenzie. Most observations concern quality system and production.

At a glance

2 of 3 observations on this 483 concern quality system.

Quality system2
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Employees engaged in the manufacture, processing, packing and holding of a drug product lack the training…

  3. 03

    There are no written procedures for production and process controls designed to assure that the drug…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at BRENNTAG PACIFIC, INC?

FDA listed 3 observations on this Form 483, mostly about quality system and production. The opening words of each observation are shown on this page.

Who inspected BRENNTAG PACIFIC, INC?

Dogbeda F. Mackenzie is named on this Form 483, for the inspection of Apr 29 – May 6, 2021. Each investigator has a profile showing what they cite most.

When was BRENNTAG PACIFIC, INC inspected by FDA?

The inspection ran Apr 29 – May 6, 2021, and the Form 483 is dated May 6, 2021.

How do I get the full Form 483 for BRENNTAG PACIFIC, INC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free